394 related articles for article (PubMed ID: 11605688)
21. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study Group.
Gordon BR; Kelsey SF; Bilheimer DW; Brown DC; Dau PC; Gotto AM; Illingworth DR; Jones PH; Leitman SF; Prihoda JS
Am J Cardiol; 1992 Oct; 70(11):1010-6. PubMed ID: 1414897
[TBL] [Abstract][Full Text] [Related]
22. Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia.
van Wijk DF; Sjouke B; Figueroa A; Emami H; van der Valk FM; MacNabb MH; Hemphill LC; Schulte DM; Koopman MG; Lobatto ME; Verberne HJ; Fayad ZA; Kastelein JJ; Mulder WJ; Hovingh GK; Tawakol A; Stroes ES
J Am Coll Cardiol; 2014 Oct; 64(14):1418-26. PubMed ID: 25277610
[TBL] [Abstract][Full Text] [Related]
23. The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy.
Yamamoto A; Harada-Shiba M; Endo M; Kusakabe N; Tanioka T; Kato H; Shoji T
Atherosclerosis; 2006 May; 186(1):126-31. PubMed ID: 16043185
[TBL] [Abstract][Full Text] [Related]
24. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
Vishwanath R; Hemphill LC
J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
[TBL] [Abstract][Full Text] [Related]
25. Role of LDL apheresis in a case of homozygous familial hypercholesterolemia.
Naveen T; Biswas A; Wig N; Soneja M; Jorwal P; Durga CS; Singla P; Chaudhary C; Baitha U
Drug Discov Ther; 2019; 13(1):59-61. PubMed ID: 30880324
[TBL] [Abstract][Full Text] [Related]
26. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
[TBL] [Abstract][Full Text] [Related]
27. Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children.
Bayrakci US; Besbas N; Ozcebe O; Coskun T; Akgul E; Kutluk T; Bakkaloglu A
Ther Apher Dial; 2005 Dec; 9(6):469-72. PubMed ID: 16354278
[TBL] [Abstract][Full Text] [Related]
28. Low-density lipoprotein apheresis by membrane differential filtration (cascade filtration) via arteriovenous fistula performed in children with familial hypercholesterolemia.
Gülle S; Bak M; Serdaroglu E; Can D; Karabay O
Ther Apher Dial; 2010 Feb; 14(1):87-92. PubMed ID: 20438523
[TBL] [Abstract][Full Text] [Related]
29. [Position of lipoprotein apheresis in present].
Bláha V; Bláha M; Lánská M; Havel E; Vyroubal P; Zadák Z; Vrablík M; Piťha J; Žák P; Sobotka L
Vnitr Lek; 2015 Nov; 61(11):958-64. PubMed ID: 26652784
[TBL] [Abstract][Full Text] [Related]
30. Treatment of severe hypercholesterolemia by LDL-apheresis: cholesterol-lowering effect and clinical evaluation.
Saito Y; Shinomiya M; Shirai K; Yoshida S
Beitr Infusionsther; 1988; 23():160-71. PubMed ID: 2484772
[No Abstract] [Full Text] [Related]
31. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.
Zwiener RJ; Uauy R; Petruska ML; Huet BA
J Pediatr; 1995 May; 126(5 Pt 1):728-35. PubMed ID: 7751996
[TBL] [Abstract][Full Text] [Related]
32. Lipidfiltration--safe and effective methodology to perform lipid-apheresis.
Klingel R; Mausfeld P; Fassbender C; Goehlen B
Transfus Apher Sci; 2004 Jun; 30(3):245-54. PubMed ID: 15172630
[TBL] [Abstract][Full Text] [Related]
33. Low-density lipoprotein levels and not mutation status predict intima-media thickness in familial hypercholesterolemia.
Fahed AC; Habib RH; Nemer GM; Azar ST; Andary RR; Arabi MT; Moubarak EM; Bitar FF; Haddad FF
Ann Vasc Surg; 2014 Feb; 28(2):421-6. PubMed ID: 24120234
[TBL] [Abstract][Full Text] [Related]
34. [Low-density lipoprotein apheresis in familial hypercholesterolemia resistant to intensive medical treatment].
Arbona C; Martinez-Hervás S; Goterris R; Montoro J; Real JT; Ascaso JF
Med Clin (Barc); 2013 Mar; 140(5):207-10. PubMed ID: 22571847
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia.
Streicher J; Valent P; Schmidt H; Sengölge G; Wagner O; Strobl W; Hörl WH; Derfler K
J Investig Med; 1999 Sep; 47(8):378-87. PubMed ID: 10510590
[TBL] [Abstract][Full Text] [Related]
36. Lipoprotein apheresis.
Moriarty PM; Hemphill L
Cardiol Clin; 2015 May; 33(2):197-208. PubMed ID: 25939293
[TBL] [Abstract][Full Text] [Related]
37. Recommendations for the use of LDL apheresis.
Thompson GR;
Atherosclerosis; 2008 Jun; 198(2):247-55. PubMed ID: 18371971
[TBL] [Abstract][Full Text] [Related]
38. [Selection criteria for treatment of severe hyperlipoproteinemias with LDL apheresis].
Bláha V; Zadák Z; Bláha M; Havel E; Solichová D; Brátová M; Malý J; Kmonícek L
Cas Lek Cesk; 1998 Jul; 137(14):424-9. PubMed ID: 9748737
[TBL] [Abstract][Full Text] [Related]
39. Therapy of severe familial heterozygous hypercholesterolemia by low-density lipoprotein apheresis with immunoadsorption: effects of the addition of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to therapy.
Jacob BG; Richter WO; Schwandt P
Clin Investig; 1993 Nov; 71(11):908-12. PubMed ID: 8312683
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns.
Koga N
Ther Apher; 1999 May; 3(2):155-60. PubMed ID: 10341391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]